Yisheng Biopharma (Singapore) Pte. Ltd.

1 in Phase 3

Quick facts

Phase 3 pipeline

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Yisheng Biopharma (Singapore) Pte. Ltd.

What is Yisheng Biopharma (Singapore) Pte. Ltd.'s pipeline?

Yisheng Biopharma (Singapore) Pte. Ltd. has 1 drugs in Phase 3, 2 in Phase 2, 1 in Phase 1. Late-stage candidates include Chirorab.

Related